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 We evaluated retrospectively the role of bronchoalveolar 
lavage (BAL) in the diagnosis of primary pulmonary B-cell 
lymphoma in four patients. Histological examination of 
transbronchial lung biopsy specimens showed nonspecific 
infiltration of small lymphocytes. Examination of BAL fluid 
(BALF) samples showed lymphocytosis in all samples with 
dominant B-cell in two patients and T-cell in the remaining 
patients. In two patients only, there was a increase in B-cell 
bearing IgM light-chain or M-protein in BALF samples. our 
results suggest that the diagnostic value of BAL in primary 
pulmonary B-cell lymphoma is limited and that new molecu-
lar biological techniques should be adapted for analysis of 
BALF samples.
Introduction 
 Various lymphoproliferative diseases containing reac-
tive and tumorous lesions may involve the lung (1), and 
it is often difficult to accurately distinguish such lesions 
by conventional radiography or small biopsy specimens 
such as transbronchial lung biopsy (TBLB). A definitive 
diagnosis in the early stages of the disease is quite impor-
tant in these cases since certain pulmonary lymphopro-
liferative disorders, especially lymphomas of the small 
lymphocytic type, frequently show malignant features 
during long the clinical course (2). A commonly used di-
agnostic procedure in pulmonary medicine is broncho-
alveolar lavage (BAL). Using a fiberoptic bronchoscope, 
BAL is a useful method for the diagnosis of various 
pulmonary diseases (3). In addition, recent advances in
immunological or molecular biological techniques have 
made BAL a more useful diagnostic procedure in several 
other diseases such as pulmonary lymphoma (4-7). In the 
present study, we analyzed samples of bronchoalveolar 
lavage fluid (BALF) obtained from four patients with 
primary pulmonary lymphomas, and retrospectively ex-
amined the diagnostic value and limitations of BAL in 
these cases.
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Patients and Methods 
Case 1 
 A 75-year-old asymptomatic nonsmoker male was ad-
mitted with infiltrate in the left lower lobe on chest 
roentgenogram in 1992. A small amount of pleural ef-
fusion with pleural thickening in the right lower region 
posteriorly was also found on computed tomography. 
Transbronchial lung biopsy (TBLB) was obtained from 
the affected area of the lung, where histological examina-
tion of the specimen showed infiltration of small lympho-
cytes. Laboratory examination showed a marked increase 
in serum IgM and IgM-kappa monoclonal gammopathy. 
A proportion of lymphocytes in pleural effusion sam-
ples were B-cells surfaced with monoclonal IgM-kappa 
light chain on it's surface. The pleural biopsy speci-
men was histologically similar to the TBLB specimen. 
Case 2 
 A 43-year-old nonsmoker female was admitted to our 
unit for further investigation of asymptomatic pulmonary 
infiltrates that had progressively increased in size during 
the last four years. The infiltrates were in the anterome-
dial segment of both lower lobes and were detected on 
a routine chest roentgenogram in 1988 (8). She had auto-
immune hemolytic anemia with increased haptoglobin
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and positive direct antiglobulin test (Coomb's test), and 
serum immunoglobulin levels were normal. Histological 
examination of TBLB specimens from both lung lesions 
showed non-specific infiltration of small lymphocytes. 
The patient underwent diagnostic segmentectomy of the 
right pulmonary lesion, where histological findings were 
compatible with those of pseudolymphoma as previously 
described by Saltzstein (9). Gene analysis of the surgi-
cal specimens showed Ig heavy-chain and kappa-chain 
genes rearrangement.
Case 3 
 A 75-year-old nonsmoker male had slowly spreading 
infiltrates without lymphadenopathy for approximately 
five years in the right upper lobe on the chest roentgeno-
gram (4). TBLB was obtained from the right upper lobe 
in 1985 and histological examination was suggestive of a 
benign pulmonary lymphoid tumor with infiltration of 
small lymphocytes with germinal centers. The serum 
IgM, however, increased gradually together with a spread 
of the infiltrate. IgM-lambda monoclonal gammopathy 
was detected in the serum and BALF by immunoelectro-
phoresis. 
Case 4 
  A 62-year-old asymptomatic nonsmoker male was ad-
mitted for further examination of infiltrates in the left 
upper lobe on the chest roentgenogram in 1985. Histolo-
gical examination of the TBLB specimen showed infiltra-
tion of small lymphocytes with germinal follicles, and
immunoperoxidase staining of the tissue showed IgM-
kappa monoclonality.
Analyses of BALF and Gene 
 In all patients, BAL of the radiographically involved 
areas was performed as previously described (10). Super-
natants obtained after centrifugation of BALF were used 
for measurement of protein fractions and immunoglobu-
lins, and immunoelectrophoresis. TBLB specimens were 
stained with hematoxylin-eosin, and the frozen sections 
were stained by using the immunoperoxidase method. 
  Gene analysis of tumors in the case 2 was performed 
by using the method reported by Fishleder et al. (11). 
DNA isolated from the tumor tissue was digested by the 
restriction-endonuclease enzyme Hind III, Bam HI/Hind 
III, or Eco RI, and size-fractionated by agarose gel electro-
phoresis. Digests transferred by Southern blotting were 
hybridized with 32P-labeled JH, J k , C/I, and Jr l probes 
(8).
Results 
 As stated above, the four TBLB specimens stained with 
hematoxylin-eosin showed infiltration of small lympho-
cytes without atypical lymphocytes and/or with germi-
nal centers. However, these histological features were not 
diagnostic for lymphoma. Although M-protein was found 
in the sera of two patients (cases 1 and 3), monoclonality 
in the biopsy specimens was not defined (Table 1). In 
case 4, only the TBLB specimen was diagnostic, where
Table 1. Serological and Pathological Analyses 
 Patient Immunoglobulin Immuno- Histological Immuno- Gene             (p
er albumin) electrophoresis finding of TBLB peroxidase stain rearrangement 
 Case 1 IgG 0.313                             M-protein small mature 
         IgA 0.053 (IgM-kappa) lymphocytes Polyclonal N.D. 
         IgM 0.765 infiltrate 
 Case 2 IgG 0.374                                         diffuse small IgH and kappa 
         IgA 0.069 Normal lymphocytes Polyclonal light chain 
          IgM 0.025 infiltrate rearrangement 
 Case 3 IgG 0.367                             M-protein small mature IgG-lambda 
         IgA 0.142 (IgM-lambda) lymphocytes N.D. 
         IgM 0.292 infiltrate (scattered) 
 Case 4 IgG 0.337 
                                             small mature Monoclonal 
         IgA 0.225 Normal lymphocytes (IgM-kappa) N.D. 
         IgM 0.029 infiltrate 
 TBLB, transbronchial lung biopsy; N.D., not done
IgM-kappa positive B-cells were diffusely stained in the 
frozen sections. 
 Lymphocyte population in BALF in all but case 4 was 
markedly increased, where the major population of lym-
phocytes was B-cell in cases 1 and 2, and T-cell in cases 3 
and 4 (Table 2). In case 1 with B-cell dominance and 
case 3 with T-cell dominance in BALF, M-protein with 
IgM-kappa and IgM-lambda was detected in the super-
natants of BALF. The ratio of IgM to albumin in BALF in 
each patient (1.815 and 0.765) was much higher than 
that in serum (1.414 and 0.292). In another B-cell domi-
nant BALF (case 2), rearrangements of Ig heavy-chain 
and kappa-chain genes were noted in the surgical speci-
men (Fig. 1). Consequently, primary pulmonary B-cell 
lymphoma was diagnosed in two patients by BALF 
analysis, in one patient by immunostaining of the TBLB 
specimen, and in the other patient by gene analysis of 
the surgical specimen. 
 Our four patients had very slow progressive pulmo-
nary lesions with a range of approximately two to more 
than ten years, and a poor response to chemotherapy.
Table 2. Analysis of Bronchoalveolar Lavage Fluid 
                        CASE 1 CASE2 CASE 3 CASE 4 
 Total cell number (x 107) 2.676 4.572 0.957 1.31 
 Lymphocyte (%) 42.3 47.9 78 16 
 Lymphocyte subset (%) 
              CD3 9.6 5.2 87 .2 79.7 
             CD4 11.2 1.8 37 37 
              CD8 5.1 3.4 55.4 31.3
             CD21 84 .5 88.9 2 2 
 Surface marker ("-B/ )'B) 16.6 12.3 Not detected Not detected 
Immunoglobulin per albumin 
             IgG 0.624 0.333 0.371 0.571 
             IgA 0.052 0.057 0.126 0.571
             IgM 1.815 0.007 1.414 0.029
 Immunoelectrophoresis M-protein M-protein 
                         (IgM-kappa) Normal (IgM-lambda) Normal
Figure 1. Southern blot analysis of DNA from surgical tumor specimen in the case 2. 
- , germline band position; R, rearranged band position. (publication permitted by Lancet Ltd., London, UK).
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Discussion 
 Pulmonary lymphoproliferative disorders include a 
variety of diseases ranging from benign to malignant 
(1). Primary pulmonary lymphoma is relatively rare 
with less than one percent of all lymphomas (12), and 
its diagnosis is often difficult. Histopathological exami-
nation of TBLB specimens allows relatively easy diag-
nosis of certain T-cell lymphomas or Hodgkin's lym-
phoma due to their characteristic morphological features 
such as cleaved, convolutes or Sterunberg-Reed cells. 
On the other hand, TBLB specimens of B-cell lymphoma, 
especially small lymphocytic type (13) or lymphocytic 
type (14), are often difficult to diagnose even after a 
thorough histopathological and immunohistochemical 
examination, and surgical specimens by thoracotomy 
may be required to establish a firm diagnosis. 
 BAL is a non-invasive and may be a useful diagnostic 
procedure in lymphoproliferative disorders. For example, 
detection of lymphoid cells in BALF with specific mor-
phologic features is quite diagnostic for Hodgkin's lym-
phoma (5-6) or plasma cell dyscrasia (15) . However, the 
presence of lymphoma cells with scanty atypism may 
make the diagnosis based on morphological changes dif-
ficult because of the degenerative changes affecting the 
cells during aspiration. Therefore, a false positive or neg-
ative diagnosis may be made. Thus, lymphoid cells in 
BALF seem to have a limited value in the diagnosis of 
lymphoproliferative disorders. At the present, to con-
firm pulmonary B-cell lymphoma by BALF, the follow-
ing finding should be detected in BALF: monoclonality 
such as monoclonal gammopathy, dominant B-cell popu-
lation, or gene rearrangement in lymphocytes. 
 Detection of monoclonal proliferation of lymphoid cells 
is important in differentiating malignant lymphomas 
from benign lymphoproliferative disorders (16). On the 
other hand, immunoperoxidase staining of lymphoid cells 
in BALF is a useful method for detecting monoclonality. 
In two of our patients, monoclonal lymphoid cells were 
detected in BALF by immunoperoxidase staining of IgM-
kappa or lambda, though monoclonality on TBLB speci-
mens could not be detected. The major population of 
BALF lymphocytes in these patients were CD21 positive 
B-cells, which were considered to represent lymphoma 
cells. Immunoperoxidase staining of BALF lymphoid cells 
is thought to be a useful method especially in B-cell 
dominant lymphoma. 
 On the other hand, monoclonality of BALF lymphocytes 
could not be detected in the two T-cell dominant lympho-
mas. Accordingly, lymphocytes in BALF from these pa-
tients were considered reactive lymphoid cells. In one 
T-cell dominant case (case 3), immunoelectrophoresis of 
the BALF supernatant was useful in detecting monoclon-
ality. Monoclonal gammopathy in BALF is considered 
to be produced by a small population of lymphoma 
cells that have originated from B-cell. For this reason, 
the presence of a much higher ratio of IgM to albumin 
in BALF than in serum supports a local production of 
the immunoglobulin (2). Immunoelectrophoresis and 
measurement of immunoglobulins and protein fraction 
in BALF supernatant may be useful in T-cell dominant 
lymphomas. 
 Using the polymerase chain reaction technique, sev-
eral studies have detected gene rearrangement in lym-
phocytes from BALF of patients with pulmonary lym-
phoma (17, 18). Accordingly, in suspicious pulmonary 
lymphoma, we recommend that cells and supernatant 
of BALF should be stored separately in a deep freezer 
for further gene or protein analysis. In conclusion, BAL is 
a safe and non-invasive method for the diagnosis of cer-
tain lung diseases, however, in primary pulmonary B-cell 
lymphoma, the method should be considered investiga-
tional at this stage. Immunological and molecular bio-
logical techniques should be extensively adapted to 
analyze BALF samples.
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